MCA underwent layoffs, with the Nashville label cuts staff and will restructure as a smaller unit under Mike Harris, ...

Roche and AbbVie have once again come up short in their attempt to gain an additional indication for their blockbuster blood ...

Tabelecleucel shows promising efficacy in treating EBV-positive PTLD, offering hope for patients resistant to previous ...

Pterosaurs were an amazing group of flying reptiles that occupied the skies around the same time that dinosaurs roamed on ...

This trial evaluated the safety, tolerability, pharmacodynamics, pharmacokinetics and clinical activity of AstraZeneca’s ...

During a live event, Mojtaba Akhtari, MD, discussed the goals and treatment approach for patients with low-risk polycythemia ...

Wound manager Teratherix has reduced its upcoming IPO from $35m to $25m, citing the need to eliminate 'hot money' on the ...

Highlights Topline data from Clarity's diagnostic Phase II trial, SABRE, showed that 64Cu-SAR-Bombesin was safe, well ...

The presentation by Dr. Farhad Ravandi of The University of Texas MD Anderson Cancer Center will highlight emerging safety, pharmacokinetics/pharmacodynamics, and early clinical activity data for ...

A man was left in hospital for nine days with amnesia and skull fractures after he was hit by a former professional boxer ...